Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 17Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Breast Neoplasms 3Head and Neck Neoplasms 2Glioblastoma 2Thrombocytosis 1Thoracic Neoplasms 1Stomach Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Oligodendroglioma 1Neoplasms, Squamous Cell 1Neoplasms by Site 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mouth Neoplasms 1Meningioma 1

Interventions

Nivolumab 2sapanisertib 1mafosfamide 1fludarabine 1avelumab 1WP 744 1Topotecan 1Temozolomide 1Spinal Puncture 1Specimen Handling 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1Afatinib 1AZD1390 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Meningeal Neoplasms × Afatinib × Clear all
NCT03711422 2022-06-14

Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC

National Cancer Centre, Singapore

Phase 1 Terminated
2 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡